Published in:
28-07-2022 | Anxiety
Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study
Published in: Journal of Cancer Survivorship | Issue 2/2023
Login to get accessAbstract
Purpose
To assess Fear of Cancer Recurrence (FCR)—its prevalence, trajectory, and relationship to several demographic and clinical characteristics, and quality of life—in a sample of peritoneal malignancy survivors, up to 5 years post-surgery.
Methods
The Fear of Cancer Recurrence Inventory—Short Form (FCRI-SF) and 36-Item Short-Form Health Survey (SF-36) were used to collect cross-sectional data from peritoneal malignancy survivors to assess their Fear of Cancer Recurrence and quality of life respectively as well as other demographic and clinical data.
Results
The results show that more than two-thirds of the participants (N = 301) experience severe/clinical FCR. FCR is relatively stable over time. Younger patients who are struggling with anxiety or depression or receiving professional mental health support at the time of the surgery are at a higher risk of FCR. FCR is associated with a worse quality of life.
Conclusions
Peritoneal malignancy survivors are at a high risk of FCR, and it compromises their psychological, mental, and social well-being (quality of life).
Implications for cancer survivors.
Raise awareness about the high risk of FCR in this population and the demographic and clinical factors that are associated with it. Encourage peritoneal malignancy services and health professionals to address FCR in this population by normalizing it and providing support for those struggling with it.